Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 216 full-time employees. The company went IPO on 2021-03-23. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The firm mainly conducts its businesses within the Chinese market.
Universe Pharmaceuticals Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Universe Pharmaceuticals Inc 주요 수익원은 Traditional Chinese Medicine Derivatives이며, 최신 수익 발표에서 수익은 32,308,735입니다. 지역별로는 China이 Universe Pharmaceuticals Inc의 주요 시장이며, 수익은 32,308,735입니다.
Universe Pharmaceuticals Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Universe Pharmaceuticals Inc의 순손실은 $-3입니다.